Join
today
Boliven PRO is more than just patent search
- Build and save lists using the powerful Lists feature
- Analyze and download your search results
- Share patent search results with your clients
Patents »
US5874084: Using complex herbal formulations to treat hot flashes
Filing Information
Patent Family
2 Claims, No Drawings
Abstract
Hot flashes (intense heat sensation, flushing, profuse sweating, palpitations, and/or sense of anxiety) in a menopausal woman may be substantially eliminated or ameliorated by administering to a woman in need of treatment an effective amount of ingestible material which has as substantially the only active ingredient a herbal complex. These exemplary herbal complex formula utilize a number of different species of herbs using the unique properties found in different parts of the plant, the root, the leaves, the aerial parts, the bark and the rhizomes.
- 1. A method of treating brief periods of at least one of intense heat sensation, flushing, profuse sweating, palpitations and sense of anxiety in a menopausal woman in need of treatment comprising administering to said menopausal woman an ingestible complex herbal formulation having active ingredients consisting essentially of a pharmacologically effective mixture expressed in weight percent as follows:______________________________________Cortex of Paeonia suffruticosa about 12.3-14.3%Cortex of Lycium chinense about 7.6%-9.6%Root of Paeonia lactiflora about 12.3-14.3%Root of Rehmania glutinosa about 12.3-14.3%Artemisia apiacea about 7.6%-9.6%Poria cocos about 12.3-14.3%Bark of Phellodendron amurense about 7.6%-9.6%Root of Blupleurum scorzoneraefolium about 7.6%-9.6%Coptis chinensis about 7.6%-9.6%Cinnamomum cassia about 3.2-5.2%.______________________________________
- 2.2. A complex herbal formulation for the treatment of brief periods of at least one of intense heat sensation, flushing, profuse sweating, palpitations and sense of anxiety in a menopausal woman in need of treatment consisting essentially of a pharmacologically effective mixture expressed in weight percent as follows:______________________________________Cortex of Paeonia suffruticosa about 12.3-14.3%Cortex of Lycium chinense about 7.6%-9.6%Root of Paeonia lactiflora about 12.3-14.3%Root of Rehmania glutinosa about 12.3-14.3%Artemisia apiacea about 7.6%-9.6%Poria cocos about 12.3-14.3%Bark of Phellodendron amurense about 7.6%-9.6%Root of Blupleurum scorzoneraefolium about 7.6%-9.6%Coptis chinensis about 7.6%-9.6%Cinnamomum cassia about 3.2-5.2%.______________________________________
References Cited
U.S. Patent Documents
Other Publications
| "Women's Diseases" by Fu ging-zhu, 1827, Quing Jing San formula. |
| Michael Murry, Information sheet for "Angelica Sinesis (Don Quai): An Herbal Formula of Symptoms of Menstrual Discomfort." Rosalba Belford/Courtney, Comparison of Chinese and Western Uses of Angelica Sinensis, Australian Journal of Med. Herbalism, vol., Dec. 1993. |
Referenced By
| Document Number | Assignee | Inventors | Issue/Pub Date |
|
US6200594
|
Vital Dynamics, Inc.
|
Joseph Michael Ernest et al.
|
Mar 2001
|
|
US6261607
|
|
Thomas Newmark et al.
|
Jul 2001
|
|
US6180106
|
Vit-Immune, L.C.
|
Robert H Keller et al.
|
Jan 2001
|
|
US6242012
|
|
Thomas Newmark et al.
|
Jun 2001
|
|
US6238707
|
|
Zhang Chun
|
May 2001
|
|
US6264995
|
|
Thomas Newmark et al.
|
Jul 2001
|
|
US6750248
|
National University of Singapore
|
Eu Leong Yong et al.
|
Jun 2004
|
|
US7052700
|
Jiangsu Kanion Pharmaceutical Co., Ltd.
|
Wei Xiao
|
May 2006
|
|
US7300676
|
CHEN JIAFANG
|
Jiafang Chen
|
Nov 2007
|
|
US6569468
|
Jiangsu Kanion Pharmaceutical Co., Ltd.
|
Wei Xiao
|
May 2003
|
|
US7691387
|
Jiangsu Kanion Pharmaceutical Co., Ltd
|
Wei Xiao
|
Apr 2010
|
|
US7700136
|
BioNovo, Inc.
|
Isaac Cohen
|
Apr 2010
|
|
US8053004
|
Starmaker Products, LLC
|
Anson Williams et al.
|
Nov 2011
|
|
US8067040
|
Jiangsu Kanion Pharmaceuticals, Co. Ltd.
|
Wei Xiao et al.
|
Nov 2011
|
|
US8092841
|
Bionovo, Inc.
|
Isaac Cohen
|
Jan 2012
|
|
US8110228
|
Bionovo, Inc.
|
Isaac Cohen
|
Feb 2012
|
|
US8119141
|
Jiangsu Kanion Pharmaceutical Co. Ltd.
|
Wei Xiao
|
Feb 2012
|
|
US8197868
|
BioNovo, Inc.
|
Isaac Cohen
|
Jun 2012
|
Patent Family
The current document is not in a family.
Boliven’s Predicted Expiration Date includes in its calculation the number of days of patent term adjustment a U.S. patent is entitled. The Predicted Expiration Date does not, currently, include in its calculation the payment of maintenance fees, the filing of any disclaimer(s), and/or patent term extension, but Boliven is working to include this information in the near future.